Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 111.2M | 92.0M | 69.3M | 79.1M |
| Cost of revenue | 83.5M | 70.8M | 54.8M | 59.5M |
| Gross profit | 27.7M | 21.2M | 14.5M | 19.6M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 5.1M | 10.2M | 5.2M | 5.0M |
| Operating income | 23.5M | 12.4M | 10.1M | 15.6M |
| Non operating interest income | ||||
| Income | 317K | 2.0M | 937K | 862K |
| Expense | 2.0M | 1.3M | 1.4M | 1.8M |
| Other income expense | — | — | — | — |
| Pretax income | 21.8M | 13.1M | 9.6M | 14.6M |
| Tax provision | 6.4M | 3.4M | 3.2M | 4.4M |
| Net income | 15.5M | 9.7M | 6.4M | 10.2M |
| Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Basic average shares | 735.0M | 735.0M | 735.0M | 735.0M |
| Diluted average shares | 735.0M | 735.0M | 735.0M | 735.0M |
| EBITDA | 24.0M | 14.6M | 11.2M | 16.6M |
| Net income from continuing op. | 21.8M | 13.1M | 9.6M | 14.6M |
| Minority interests | -5.8M | -2.4M | -2.6M | -3.0M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |